Who We Are
NangioTx’ team is made up of qualified experts in with extensive experience. Founders Dr. Kumar (CEO) a Bioengineer & Dr. Hartgerink (CTO) a Chemist have over 35 years of biomedical-research experience and produced over 100 publications in the areas of biomaterials and tissue engineering.
NangioTx is now building its team to translate V-10 into a therapeutic product. Leading the initiative for Investigational New Drug (IND) studies is Chief Scientific Officer (Dr. Karel Petrak).